Viral evolution and escape during primary human immunodeficiency virus-1 infection: implications for vaccine design

被引:7
|
作者
Mullins, James I. [2 ,3 ]
Rolland, Morgane [2 ,3 ]
Allen, Todd M. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr, Boston, MA USA
[2] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
evolution; HIV; T lymphocyte; viral proteins;
D O I
10.1097/COH.0b013e3282f233d9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review The ability of human immunodeficiency virus to mutate rapidly to evade host immune pressures is a key hurdle limiting the control of human immunodeficiency virus-1 by cellular immune responses. Viral escape from CD8(+) T-cell recognition continues to be studied extensively, and emerging data provide greater appreciation of the affect of these mutations on the virus. These data may help identify key immune responses capable of suppressing viral replication. This goal remains critical, as current vaccines are unlikely to produce protective T-cell immunity. Recent findings Recent studies provide greater understanding of the propensity for transmitted mutations to revert, and of the ability of CD8(+) T-cell escape mutations to impact viral replication capacity and protein structure. These observations reveal important constraints on virus evolution and sequence diversity. Data are also accumulating for the ability of the immune system to mount de-novo CD8(+) T-cell responses against escape variants, revealing an underappreciated complexity of the process of viral escape. Summary Understanding the limits of sequence variation and the impact of immune escape mutations on viral fitness, particularly during acute infection, will be critical to guide the design of contemporary vaccines or therapeutics attempting to force human immunodeficiency viruses to become less fit.
引用
收藏
页码:60 / 66
页数:7
相关论文
共 50 条
  • [1] Viral Escape in the Central Nervous System with Multidrug-Resistant Human Immunodeficiency Virus-1
    Beguelin, C.
    Vazquez, M.
    Bertschi, M.
    Yerly, S.
    de Jong, D.
    Gutbrod, K.
    Rauch, A.
    Cusini, A.
    OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (01):
  • [2] Finding a Cure for Human Immunodeficiency Virus-1 Infection
    Blankson, Joel N.
    Siliciano, Janet D.
    Siliciano, Robert F.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2014, 28 (04) : 633 - +
  • [3] Dynamics of Human Immunodeficiency Virus-1 Genetic Diversification During Acute Infection
    Song, Hongshuo
    Bose, Meera
    Pinyakorn, Suteeraporn
    Sanders-Buell, Eric
    O'Sullivan, Anne Marie
    Silas, Daniel
    Trichavaroj, Rapee
    Nuntapinit, Bessara
    Pham, Phuc T.
    Akapirat, Siriwat
    Kroon, Eugene
    de Souza, Mark
    Gramzinski, Robert
    Michael, Nelson L.
    Robb, Merlin L.
    Vasan, Sandhya
    Tovanabutra, Sodsai
    Ananworanich, Jintanat
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (10): : 1 - 4
  • [4] Human Immunodeficiency Virus Infection in Alabama Women: Sociodemographic, Behavioral, and Reproductive Health Characteristics and Factors Associated With Lack of Human Immunodeficiency Virus-1 Viral Control
    Bhatta, Madhav P.
    Vermund, Sten H.
    Hoesley, Craig J.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (02) : 133 - 140
  • [5] Antibody responses and virus escape: implications for HIV-1 vaccine and therapeutic design
    Tomaras, Georgia D.
    Shen, Xiaoying
    Greenberg, Michael L.
    FUTURE VIROLOGY, 2006, 1 (01) : 79 - 88
  • [6] Human immunodeficiency virus-1 and preconception care
    Lampe, Margaret A.
    MATERNAL AND CHILD HEALTH JOURNAL, 2006, 10 (05) : S193 - S195
  • [7] Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?
    Vanham, Guido
    Van Gulck, Ellen
    RETROVIROLOGY, 2012, 9
  • [8] Can immunotherapy be useful as a “functional cure” for infection with Human Immunodeficiency Virus-1?
    Guido Vanham
    Ellen Van Gulck
    Retrovirology, 9
  • [9] Human Immunodeficiency Virus-1 and Preconception Care
    Margaret A. Lampe
    Maternal and Child Health Journal, 2006, 10 : 195 - 197
  • [10] Human immunodeficiency virus infection and viral hepatitis
    Soriano, Vicente
    Martin-Carbonero, Luz
    Vispo, Eugenia
    Labarga, Pablo
    Barreiro, Pablo
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 (09): : 691 - 701